LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 1 | E23 | 72 | hr | 1235 | 3198 | 4119 | 0.7764 | 0.7288 |
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 2 | E23 | 72 | hr | 1235 | 3339 | 4356 | 0.7665 | 0.7278 |
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 3 | E23 | 72 | hr | 1235 | 3786 | 4326 | 0.8751 | 0.8577 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 1 | E22 | 72 | hr | 1235 | 2861 | 4119 | 0.6946 | 0.6215 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 2 | E22 | 72 | hr | 1235 | 3076 | 4356 | 0.7061 | 0.6516 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 3 | E22 | 72 | hr | 1235 | 3093 | 4326 | 0.7149 | 0.6612 |
MCF7 | Dovitinib | 1.11 | uM | LJP5 | 1 | E21 | 72 | hr | 1235 | 2822 | 4119 | 0.6851 | 0.6088 |
MCF7 | Dovitinib | 1.11 | uM | LJP5 | 2 | E21 | 72 | hr | 1235 | 2759 | 4356 | 0.6333 | 0.5557 |
MCF7 | Dovitinib | 1.11 | uM | LJP5 | 3 | E21 | 72 | hr | 1235 | 2967 | 4326 | 0.6858 | 0.6234 |
MCF7 | Dovitinib | 3.33 | uM | LJP5 | 1 | E20 | 72 | hr | 1235 | 2166 | 4119 | 0.5258 | 0.3815 |
MCF7 | Dovitinib | 3.33 | uM | LJP5 | 2 | E20 | 72 | hr | 1235 | 2232 | 4356 | 0.5124 | 0.3845 |
MCF7 | Dovitinib | 3.33 | uM | LJP5 | 3 | E20 | 72 | hr | 1235 | 2247 | 4326 | 0.5194 | 0.3921 |
MCF7 | Dovitinib | 10 | uM | LJP5 | 1 | E19 | 72 | hr | 1235 | 2211 | 4119 | 0.5368 | 0.3980 |
MCF7 | Dovitinib | 10 | uM | LJP5 | 2 | E19 | 72 | hr | 1235 | 2210 | 4356 | 0.5073 | 0.3770 |
MCF7 | Dovitinib | 10 | uM | LJP5 | 3 | E19 | 72 | hr | 1235 | 2170 | 4326 | 0.5016 | 0.3655 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 1 | F24 | 72 | hr | 1235 | 2317 | 4119 | 0.5625 | 0.4362 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 2 | F24 | 72 | hr | 1235 | 2747 | 4356 | 0.6306 | 0.5520 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 3 | F24 | 72 | hr | 1235 | 2901 | 4326 | 0.6705 | 0.6034 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 1 | F23 | 72 | hr | 1235 | 2085 | 4119 | 0.5062 | 0.3515 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 2 | F23 | 72 | hr | 1235 | 2103 | 4356 | 0.4828 | 0.3399 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 3 | F23 | 72 | hr | 1235 | 2451 | 4326 | 0.5665 | 0.4607 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 1 | F22 | 72 | hr | 1235 | 2023 | 4119 | 0.4911 | 0.3283 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 2 | F22 | 72 | hr | 1235 | 2115 | 4356 | 0.4855 | 0.3441 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 3 | F22 | 72 | hr | 1235 | 2368 | 4326 | 0.5473 | 0.4331 |
MCF7 | GSK 690693 | 1.11 | uM | LJP5 | 1 | F21 | 72 | hr | 1235 | 1932 | 4119 | 0.4690 | 0.2935 |